Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline
Open accessThe DOI matches its Crossref record; 213 of the 213 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The objective is to formulate clinical practice guidelines for treating Cushing's syndrome. PARTICIPANTS: Participants include an Endocrine Society-appointed Task Force of experts, a methodologist, and a medical writer. The European Society for Endocrinology co-sponsored the guideline. EVIDENCE: The Task Force used the Grading of Recommendations, Assessment, Development, and Evaluation system to describe the strength of recommendations and the quality of evidence. The Task Force commissioned three systematic reviews and used the best available evidence from other published systematic reviews and individual studies. CONSENSUS PROCESS: The Task Force achieved consensus through one group meeting, several conference calls, and numerous e-mail communications. Committees and members of The Endocrine Society and the European Society of Endocrinology reviewed and commented on preliminary drafts of these guidelines. CONCLUSIONS: Treatment of Cushing's syndrome is essential to reduce mortality and associated comorbidities. Effective treatment includes the normalization of cortisol levels or action. It also includes the normalization of comorbidities via directly treating the cause of Cushing's syndrome and by adjunctive treatments (eg, antihypertensives). Surgical resection of the causal lesion(s) is generally the first-line approach. The choice of second-line treatments, including medication, bilateral adrenalectomy, and radiation therapy (for corticotrope tumors), must be individualized to each patient.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The guidelines provide a general definition of remission after resection of an ACTH-producing corticotroph tumor as morning serum cortisol levels <5 μg/dL (<138 nmol/L) or UFC <28-56 nmol/d (<10-20 μg/d) within 7 days of tumor resection (37).”
From Measuring cortisol in Cushing syndrome: diagnosis, monitoring, and cortisol circadian rhythm improvement. (2026) · cites this paper as [37]
In the citing paper
“Steroidogenesis inhibitors work by inhibiting one or more enzymes involved in steroidogenesis, decreasing cortisol and other steroid hormone production (37, 38).”
From Measuring cortisol in Cushing syndrome: diagnosis, monitoring, and cortisol circadian rhythm improvement. (2026) · cites this paper as [37]
In the citing paper
“Available medical therapies currently used in clinical practice to treat CS include medications from 3 classes: pituitary-directed therapies (for pituitary CD only), steroidogenesis inhibitors, and glucocorticoid receptor antagonists (37).”
From Measuring cortisol in Cushing syndrome: diagnosis, monitoring, and cortisol circadian rhythm improvement. (2026) · cites this paper as [37]
In the citing paper
“In patients with CS, surgical resection of the causative lesion(s) is the first-line treatment option regardless of etiology.”
From Measuring cortisol in Cushing syndrome: diagnosis, monitoring, and cortisol circadian rhythm improvement. (2026) · cites this paper as [37]
In the citing paper
“Pituitary-directed therapies, including pasireotide (US/EU/Canada) and cabergoline (off-label use only), inhibit pituitary ACTH production and, in some cases, ectopic ACTH secretion from neuroendocrine tumors, thereby reducing downstream cortisol secretion (37, 128).”
From Measuring cortisol in Cushing syndrome: diagnosis, monitoring, and cortisol circadian rhythm improvement. (2026) · cites this paper as [37]
9 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Kearon (2012) · doi:10.1378/chest.11-2301 · Cited by 6,119
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0125 · Cited by 2,718 · cited 2×
“(17) 2810 Nieman et al Guidelines on Cushing’s Syndrome Treatment J Clin Endocrinol Metab, August 2015, 100(8):2807–2831”
BackgroundSelf-citationKahn (2012) · doi:10.1378/chest.11-2296 · Cited by 2,693
Self-citationPrevention of VTE in Nonorthopedic Surgical Patients
Gould, M. K., Garcia, D. A., Wren, S. M., Karanicolas, P. J., Arcelus, J. I., Heit, J. A., & Samama, C. M. (2012) · Chest · doi:10.1378/chest.11-2297 · Cited by 2,131
Lacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777
Self-citationMolitch, M. E., Clemmons, D. R., Malozowski, S., Merriam, G. R., & Vance, M. L. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0179 · Cited by 1,047
Cushing, H. (1964) · Journal of Neurosurgery · doi:10.3171/jns.1964.21.4.0318 · Cited by 851
Starkman, M. N., Gebarski, S. S., Berent, S., & Schteingart, D. E. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90079-f · Cited by 840
The natural history of cushing's syndrome
Plotz, C. M., Knowlton, A. I., & Ragan, C. (1952) · The American Journal of Medicine · doi:10.1016/0002-9343(52)90027-2 · Cited by 763
Cited by
Items 501–600 of 1,000
Mirallas, O., Filippi-Arriaga, F., Hernández, I., Aubanell, A., Chaachou-Charradi, A., García‐Álvarez, A., Hernando, J., Martínez-Sáez, E. A., Biagetti, B., & Capdevila, J. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.731631 · Cited by 11
Preventive strategies for hypercoagulation in Cushing’s syndrome: when and how
Lopes, V., Marques, O., & Lages, A. D. S. (2023) · Thrombosis Journal · doi:10.1186/s12959-023-00515-1 · Cited by 11
Yuen, K. C. J., Moraitis, A. G., & Nguyen, D. (2017) · Journal of the Endocrine Society · doi:10.1210/js.2016-1097 · Cited by 11
Guarnotta, V., Pizzolanti, G., Ciresi, A., & Giordano, C. S. D. S. (2018) · Journal of Endocrinological Investigation · doi:10.1007/s40618-018-0839-7 · Cited by 11
Pasternak-Pietrzak, K., Moszczyńska, E., & Szalecki, M. (2019) · Endocrine · doi:10.1007/s12020-019-02036-2 · Cited by 11
Surgical approach to patients with hypercortisolism
Kiernan, C. M., & Solórzano, C. C. (2020) · Gland Surgery · doi:10.21037/gs.2019.12.13 · Cited by 11
A Novel Diagnostic Model for Primary Adrenal Lymphoma
Yu, K., Xue, Q., Zhou, F., Tian, H., Xiang, Q., Chen, T., & Ren, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.636658 · Cited by 11
Lipocrinology – the relationship between lipids and endocrine function
Kalra, S., & Priya, G. (2018) · Drugs in Context · doi:10.7573/dic.212514 · Cited by 11
Theodorou, A., Tan, E. C., Bakkar, M. A., Reiner, A. S., Sazo, M., Cohen, M. A., Lin, A. L., Tabar, V. S., & Geer, E. B. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf598 · Cited by 10
Stalla, G. K., Ciato, D., & Dimopoulou, C. (2018) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0664-7632 · Cited by 10
Wong, S. W. P., Yap, Y. W., Narayanan, R. P., Al-Jubouri, M., Grossman, A. B., Daousi, C., & Mahgoub, Y. (2019) · Endocrinology Diabetes and Metabolism Case Reports · doi:10.1530/edm-19-0044 · Cited by 10
Zhang, W., Li, D., Feng, M., Hu, B., Fan, Y., Chen, Q., & Wang, R. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.754882 · Cited by 10
Surgical Experience of Transcranial Approaches to Large-to-Giant Pituitary Adenomas in Knosp Grade 4
Guan, X., Wang, Y., Zhang, C., Ma, S., Zhou, W., Jia, G., & Jia, W. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.857314 · Cited by 10
Hypothalamo-Pituitary-Adrenal Axis in Depressive Disorders and Treatment Resistance
Yunilaynen, O. A., Starostina, E. G., & Oleichik, I. V. (2023) · Psikhiatriya · doi:10.30629/2618-6667-2023-21-1-73-90 · Cited by 10
McKevitt, C., Gabriel, E., Marenco-Hillembrand, L., Otamendi-Lopez, A., Jeevaratnam, S., Almeida, J. P., Samson, S. L., & Chaichana, K. L. (2023) · Scientific Reports · doi:10.1038/s41598-023-42157-3 · Cited by 10
Findlay, M. C., Drexler, R., Azab, M. A., Karbe, A., Rotermund, R., Ricklefs, F. L., Flitsch, J., Smith, T. R., Kilgallon, J. L., Honegger, J. B., et al. (2023) · World Neurosurgery · doi:10.1016/j.wneu.2023.09.076 · Cited by 10
Działach, Ł., Sobolewska, J., Respondek, W., Szamotulska, K., & Witek, P. (2023) · Biomedicines · doi:10.3390/biomedicines11123227 · Cited by 10
Calandrelli, R., Mattogno, P. P., Chiloiro, S., Gessi, M., D’Apolito, G., Tartaglione, T., Giampietro, A., Bianchi, A., Doglietto, F., Lauretti, L., et al. (2024) · Diagnostics · doi:10.3390/diagnostics14030274 · Cited by 10
Ding, H., Wu, X. J., Wu, B. W., Li, X., Pan, L. S., Xie, S., Zhan, J., Tang, B., & Hong, T. (2024) · Journal of neurosurgery · doi:10.3171/2023.12.jns23922 · Cited by 10
Johnson, S., Zhang, C. D., Hangge, P. T., Yen, T. W. F., Shaik, T., Doffek, K. M., Findling, J. W., Carroll, T. B., Evans, D. B., Dream, S. Y., et al. (2024) · Annals of Surgical Oncology · doi:10.1245/s10434-024-15773-0 · Cited by 10
Self-citationWho and how to screen for endogenous hypercortisolism in patients with mood disorders
Ferrante, E., Simeoli, C., Mantovani, G., & Pivonello, R. (2024) · Journal of Endocrinological Investigation · doi:10.1007/s40618-024-02457-5 · Cited by 10
National German Audit of Diagnosis, Treatment, and Teaching in Secondary Adrenal Insufficiency
Petersenn, S., Honegger, J. B., & Quinkler, M. O. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-105077 · Cited by 10
Daniel, E., & Newell-Price, J. D. C. (2017) · F1000Research · doi:10.12688/f1000research.10968.1 · Cited by 10
Self-citationSoundarrajan, M., Zelada, H., Fischer, J. V., & Kopp, P. A. (2018) · AACE Clinical Case Reports · doi:10.4158/accr-2018-0429 · Cited by 10
Serban, A. L., Rosso, L., Mendogni, P., Cremaschi, A., Indirli, R., Mantovani, B., Rumi, M. G., Castellani, M., Chiti, A., Croci, G. A., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.687539 · Cited by 10
Challenging Case of Ectopic ACTH Secretion from Prostate Adenocarcinoma
Zeng, W., & Khoo, J. J. C. (2022) · Case Reports in Endocrinology · doi:10.1155/2022/3739957 · Cited by 10
Role of Radiation in the treatment of Cushing Disease
Katznelson, L. J. (2022) · Pituitary · doi:10.1007/s11102-022-01234-y · Cited by 10
Martino, M., Aboud, N., Lucchetti, B., Salvio, G., & Arnaldi, G. (2023) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2023.2192349 · Cited by 10
Page‐Wilson, G., Oak, B., Silber, A., Okeyo, J. C., Ortiz, N., O’Hara, M., Moloney, S., & Geer, E. B. (2023) · Pituitary · doi:10.1007/s11102-023-01314-7 · Cited by 10
Cell Cycle Regulators and Lineage-Specific Therapeutic Targets for Cushing Disease
Araki, T., & Liu, N. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00444 · Cited by 10
Filamin A and DRD2 expression in corticotrophinomas
Sickler, T. D. P., Trarbach, E. B., Frassetto, F. P., Dettoni, J. B., Alves, V. A. F., Fragoso, M. C. B. V., Machado, M. C., Cardoso, E. F., Bronstein, M. D., & Glezer, A. (2019) · Pituitary · doi:10.1007/s11102-019-00947-x · Cited by 10
Reversibility of cerebral blood flow in patients with Cushing's disease after surgery treatment
Cheng, H., Gao, L., Hou, B., Feng, F., Guo, X., Wang, Z., Feng, M., Xing, B., & Fan, Y. (2019) · Metabolism · doi:10.1016/j.metabol.2019.154050 · Cited by 10
Ramos-Prudencio, R., Álvarez, S. I. P., Flores-Balcázar, C. H., de León-Alfaro, M. A., Herrera-González, J. A., Elizalde-Cabrera, J., Rubalcava‐Ortega, J., Espinoza-Alvarado, L., & Balderrama-Ibarra, R. I. (2020) · Reports of Practical Oncology & Radiotherapy · doi:10.1016/j.rpor.2020.04.020 · Cited by 10
Síndrome de Cushing ectópico: revisión de la literatura
Gutiérrez-Restrepo, J., & Román-Gonzaléz, A. (2016) · Revista Colombiana de Cancerología · doi:10.1016/j.rccan.2016.03.001 · Cited by 10
Disorders of the adrenal cortex
Sherlock, M., & Gurnell, M. (2020) · doi:10.1093/med/9780198746690.003.0249 · Cited by 10
Postoperative Considerations Following Pituitary Surgery: A Guide for Clinicians
Giraldi, E. A., & Ioachimescu, A. G. (2025) · Endocrine Practice · doi:10.1016/j.eprac.2025.06.018 · Cited by 9
Paragliola, R. M., Marchetti, M., Montagna, C., Corsello, S. M., & Peluso, G. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262211230 · Cited by 9
Nowak, E., Viëtor, C. L., Feelders, R. A., Hofland, J., Araujo-Castro, M., Ojeda, C. M., Corrales, E. P., Salama, B., Bancos, I., Sandooja, R., et al. (2026) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(25)00302-x · Cited by 9
Self-citationGao, Y., Wang, M., Wu, Y., Deng, H., Xu, Y., Ren, Y., Wang, C., & Wang, W. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12041288 · Cited by 9
Surveillance Imaging Strategies for Pituitary Adenomas: When, How Frequent, and When to Stop
Yuen, K. C. J., Ghalib, L. M., Buchfelder, M., Hughes, J. N., Langlois, F., & Molitch, M. E. (2023) · Endocrine Practice · doi:10.1016/j.eprac.2023.12.014 · Cited by 9
Boehm, E., Hung, T., Akhurst, T. J., Alipour, R., Chiang, C. Y., Hicks, R. J., Hofman, M. S., Kumar, A. S. R., Sachithanandan, N., Saghebi, J., et al. (2024) · Endocrine Oncology · doi:10.1530/eo-24-0013 · Cited by 9
Approach to the Patient With Cyclical Cushing Syndrome
Ferrière, A., Nunes, M. L., & Tabarin, A. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae864 · Cited by 9
Self-citationLong-term outcome of trans-sphenoidal surgery for Cushing’s disease in Indian patients
Saini, S., Kanwar, J., Gupta, S. K., Behari, S., Bhatia, E., & Yadav, S. (2018) · Acta Neurochirurgica · doi:10.1007/s00701-018-3736-0 · Cited by 9
Bray, D. P., Rindler, R. S., Dawoud, R. A., Boucher, A. B., & Oyesiku, N. M. (2022) · Otolaryngologic Clinics of North America · doi:10.1016/j.otc.2021.12.006 · Cited by 9
Genetically predicted cortisol levels and risk of venous thromboembolism
Allara, E., Lee, W., Burgess, S., & Larsson, S. C. (2022) · PLoS ONE · doi:10.1371/journal.pone.0272807 · Cited by 9
Canat, M. M., Turkkan, C. Y., Erhan, H., Öztürk, F. Y., & Altuntaş, Y. (2023) · SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital · doi:10.14744/semb.2023.14306 · Cited by 9
Nowotny, H. F., Seiter, T. M., Ju, J., Gottschlich, A., Schneider, H., Zopp, S., Vogel, F., Tschaidse, L., Auer, M. K., Lottspeich, C., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1275828 · Cited by 9
Cushing Syndrome Is Associated With a Higher Risk of Cancer—A Nationwide Cohort Study
Wu, W.-C., Wu, J.-L., Huang, T., Li, C., & Li, H. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae405 · Cited by 9
Medical Treatment of Cushing’s Disease
Hopkins, S., & Fleseriu, M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804340-0.00007-3 · Cited by 9
Tang, K., Wang, L., Yang, Z., Sui, Y., Li, L., Huang, Y.-T., & Gao, P. (2017) · Oncotarget · doi:10.18632/oncotarget.20597 · Cited by 9
Chai, S. T., Tajuddin, A. H. A., Wahab, N. A., Mustafa, N., Sukor, N., & Kamaruddin, N. A. (2018) · Intern J Endocrinol Metab · doi:10.5812/ijem.65233 · Cited by 9
Yi, L. S., Alias, A., Ghani, A. R. I., & Bidin, M. B. L. (2019) · Malaysian Journal of Medical Sciences · doi:10.21315/mjms2019.26.3.5 · Cited by 9
Hannan, C. J., Daousi, C., Radon, M. R., & Gilkes, C. E. (2021) · British Journal of Neurosurgery · doi:10.1080/02688697.2021.1981237 · Cited by 9
Treatment of Aggressive Pituitary Adenomas: A Case-Based Narrative Review
Cooper, O. B., Bonert, V. S., Liu, N., & Mamelak, A. N. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.725014 · Cited by 9
van der Meulen, M., Verstegen, M. J. T., Lobatto, D. J., Kleijwegt, M. C., Pereira, A. M., Biermasz, N. R., van Furth, W. R., & Najafabadi, A. H. Z. (2022) · Pituitary · doi:10.1007/s11102-021-01199-4 · Cited by 9
Yedinak, C. G., Hopkins, S., Williams, J. N., Ibrahim, A., Cetas, J. S., & Fleseriu, M. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00035 · Cited by 9
Decaestecker, K., Wijtvliet, V. P. W. M., Coremans, P., & Doninck, N. V. (2019) · Endocrinology Diabetes and Metabolism Case Reports · doi:10.1530/edm-19-0093 · Cited by 9
Newell-Price, J. D. C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804169-7.00017-9 · Cited by 9
Self-citationAre there Reliable Predictors for the Impaired Quality of Life in Patients With Cushing’s Syndrome?
Nankova, A., Yaneva, M., Elenkova, A., Kalinov, K., & Zacharieva, S. (2019) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2019.482 · Cited by 9
Tan, H., Chen, D., Yu, Y., Yu, K., He, W., Cai, B., Jiang, S., Tang, Y., Tong, N., & An, Z. (2020) · BMC Endocrine Disorders · doi:10.1186/s12902-020-00590-9 · Cited by 9
Bunevičius, A., Lavezzo, K., Smith, P. W., Vance, M. L., & Sheehan, J. P. (2021) · Acta Neurochirurgica · doi:10.1007/s00701-021-04823-1 · Cited by 9
Daniel, E., & Newell-Price, J. D. C. (2017) · Medicine · doi:10.1016/j.mpmed.2017.05.007 · Cited by 9
Self-citationHypertension in Cushing’s Syndrome
Ceccato, F., Barbot, M., Scaroni, C. M., & Boscaro, M. (2020) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-030-45562-0_8 · Cited by 9
Spanish consensus on the diagnosis and management of adrenocortical carcinoma
Castro, M. A., Álvarez-Escolá, C., Casteràs, A., Carmona‐Bayonas, A., Chiara, M., Hanzu, F. A., Hernando, J., Vercher-Conejero, J. L., Rodríguez‐Fraile, M., Santos, V. G. D., et al. (2025) · Endocrine Related Cancer · doi:10.1530/erc-25-0034 · Cited by 8
Lillehei, K. O., Travers, S. S., Barkhoudarian, G., Oyesiku, N. M., Germano, I. M., & Ormond, D. R. (2025) · Neurosurgery · doi:10.1227/neu.0000000000003559 · Cited by 8
Parksook, W. W., Laichuthai, N., & Sunthornyothin, S. (2020) · Case Reports in Endocrinology · doi:10.1155/2020/2946868 · Cited by 8
Predicting delayed remission in Cushing’s disease using radiomics models: a multi-center study
Zhang, W., Zhang, D., Liu, S., Wang, H., Liu, X.-H., Dai, C., Fang, Y., Fan, Y., Wei, Z., Feng, M., et al. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2023.1218897 · Cited by 8
Shah, H., Slavin, A., Botvinov, J., O’Malley, G. R., Sarwar, S. A., & Patel, N. V. (2024) · World Neurosurgery · doi:10.1016/j.wneu.2024.03.135 · Cited by 8
Xiao, L., Wu, B., Ding, H., He, Y., Wu, X., Xie, S., Tang, B., & Hong, T. (2024) · Operative Neurosurgery · doi:10.1227/ons.0000000000001193 · Cited by 8
High LDL Particle and APOB Concentrations in Patients With Adrenal Cortical Adenomas
Sandooja, R., Saini, J., Kittithaworn, A., Garcia, R. G., Dogra, P., Atkinson, E. J., Yu, K., Fell, V. M., Simha, V., Connelly, M. A., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae392 · Cited by 8
Advancement in perioperative management of pituitary adenomas—Current concepts and best practices
Shafiq, I., Williams, Z. R., & Vates, G. E. (2024) · Journal of Neuroendocrinology · doi:10.1111/jne.13427 · Cited by 8
How to manage Cushing's disease after failed primary pituitary surgery
Agrawal, N., Urwyler, S. A., Mehta, S., Karavitaki, N., & Feelders, R. A. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae110 · Cited by 8
Hormone circuit explains why most HPA drugs fail for mood disorders and predicts the few that work
Milo, T., Halber, S. N., Raz, M., Danan, D., Mayo, A., & Alon, U. S. (2025) · Molecular Systems Biology · doi:10.1038/s44320-024-00083-0 · Cited by 8
Walia, R., Chakraborty, A. M., Pandey, S., Rana, N., Kumar, R., Ahuja, C. K., Singh, H., Dhandapani, S., Sahoo, S. K., Chhabra, R., et al. (2025) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-025-07304-0 · Cited by 8
Guarnotta, V., Stigliano, A., Terzolo, M., & Arnaldi, G. (2025) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-025-09989-y · Cited by 8
Chen, S., Li, R., Zhang, X., Lü, L., Ji, L., Pan, H., & Zhu, H. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01977 · Cited by 8
Zhang, W., Zhu, K., Li, H., Zhang, Y., Zhu, D., Zhang, X., & Li, P. (2019) · International Journal of Endocrinology · doi:10.1155/2019/2860810 · Cited by 8
Wierman, M. E. (2021) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2020.12.003 · Cited by 8
The role of reoperation after recurrence of Cushing’s disease
Cardinal, T. M., Zada, G., & Carmichael, J. D. (2021) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2021.101489 · Cited by 8
Shi, X., Du, T., Zhu, D. Y., Ma, D., Dong, K., Peng, X., Huang, J., Lei, T., Yu, X., Chen, J., et al. (2021) · Endocrine · doi:10.1007/s12020-021-02891-y · Cited by 8
Diagnostic Impact of Adrenal Vein Sampling in Adrenal Cushing's Syndrome
Raje, P., Broekhuis, J. M., Sacks, B. A., & James, B. C. (2021) · Journal of Surgical Research · doi:10.1016/j.jss.2021.08.006 · Cited by 8
Hipertensão secundária: abordagem nos cuidados de saúde primários
de Família, M., Costa, T. F. D. C., Leitão, D. C. C. B., & de Família, M. (2021) · Revista Portuguesa de Clínica Geral · doi:10.32385/rpmgf.v37i6.12722 · Cited by 8
Surgical treatment of adrenal tumors during pregnancy
Bartz-Kurycki, M. A., Dream, S. Y., & Wang, T. S. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-022-09744-7 · Cited by 9
Structural and functional brain alterations in Cushing’s disease: A narrative review
Liu, Y.-F., Pan, L., & Feng, M. (2022) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2022.101033 · Cited by 8
Intensity-modulated radiotherapy for cushing’s disease: single-center experience in 70 patients
Lian, X., Xu, Z., Sun, S., Wang, W., Zhu, H., Lü, L., Hou, X., & Zhang, F. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1241669 · Cited by 8
Paraneoplastic Syndromes in Neuroendocrine Prostate Cancer: A Systematic Review
Abufaraj, M. M., Ramadan, R., & Alkhatib, A. (2024) · Current Oncology · doi:10.3390/curroncol31030123 · Cited by 8
Itonaga, T., Goto, H., Toujigamori, M., Ohno, Y., Korematsu, S., Izumi, T., Narumi, S., Hasegawa, T., & Ihara, K. (2017) · Hormone Research in Paediatrics · doi:10.1159/000473878 · Cited by 8
Pasternak-Pietrzak, K., Stratakis, C. A., Moszczyńska, E., Lecka-Ambroziak, A., Staniszewski, M., Wątrobińska, U., Lyssikatos, C., Prokop-Piotrkowska, M., Grajkowska, W., Pronicki, M., et al. (2018) · Endokrynologia Polska · doi:10.5603/ep.a2018.0063 · Cited by 8
Behavioral and steroidogenic pharmacology of phenyl ring substituted etomidate analogs in rats
McGrath, M., Hofmann, A., & Raines, D. E. (2019) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-019-0328-4 · Cited by 8
Endocrine Tumor Board: Ten Years’ Experience of a Multidisciplinary Clinical Working Conference
Savitz, A. C., Fong, B. P., Hochberg, A. R., Rumore, G. J., Cui, C., Yun, J., & Sadur, C. N. (2020) · The Permanente Journal · doi:10.7812/tpp/19.140 · Cited by 8
The impact of adrenal tumor multidisciplinary team meetings on clinical outcomes
Fukuoka, H., Shigemura, K., Kanzawa, M., Kanda, T., Yamamoto, M., Kitagawa, K., Sakamoto, M., Iguchi, G., Ogawa, W., Fujisawa, M., et al. (2020) · Endocrine · doi:10.1007/s12020-020-02361-x · Cited by 8
Persistent Cushing’s Disease after Transsphenoidal Surgery: Challenges and Solutions
Albani, A., & Theodoropoulou, M. (2020) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1220-6056 · Cited by 8
Wijewickrama, P. S. A., Ratnasamy, V., Somasundaram, N. P., Sumanatilleke, M., & Ambawatte, S. B. (2021) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00701-0 · Cited by 8
Moszczyńska, E., Marczak, E., Szalecki, M., Kądziołka, K., Roszkowski, M., & Zagata-Lesnicka, P. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.650967 · Cited by 8
Metabolic profile differences in ACTH‐dependent and ACTH‐independent Cushing syndrome
Li, Z., Zhang, C., Geng, C., & Song, Y. (2021) · Chronic Diseases and Translational Medicine · doi:10.1016/j.cdtm.2021.08.004 · Cited by 8
Moreno-Moreno, P., Ibáñez‐Costa, A., Venegas-Moreno, E. M., Fuentes-Fayos, A. C., Alhambra-Expósito, M. R., Fajardo, C., García‐Martínez, A., Dios, E., Vazquez-Borrego, M. C., Remón-Ruiz, P., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac172 · Cited by 9
Corticotroph tumor progression after bilateral adrenalectomy: data from ERCUSYN
Valassi, E., Castinetti, F., Ferrière, A., Tsagarakis, S., Feelders, R. A., Netea-Maier, R. T., Droste, M., Strasburger, C. J., Maiter, D. M., Kaštelan, D., et al. (2022) · Endocrine Related Cancer · doi:10.1530/erc-22-0074 · Cited by 8
Tan, C., & Triay, J. (2023) · Endocrinology Diabetes and Metabolism Case Reports · doi:10.1530/edm-22-0347 · Cited by 8
Therapeutic compounds for Cushing’s syndrome: a patent review (2012-2016)
Ma, L., Yin, L., & Hu, Q. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2016.1217331 · Cited by 8
Wagner, J., Fleseriu, C. M., Ibrahim, A., & Cetas, J. S. (2016) · World Neurosurgery · doi:10.1016/j.wneu.2016.09.008 · Cited by 8
Metadata
- Authors
- Nieman, L. K., Biller, B. M. K., Findling, J. W., Murad, M. H., Newell-Price, J., Savage, M. O., & Tabarin, A.
- Affiliations
- National Institutes of Health (US)
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2015-08
- Volume
- 100
- Issue
- 8
- Pages
- 2807-2831
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC4525003
- OpenAlex
- W2127952551
- Semantic Scholar
- 4d26bfff9a2f2ea132ea661d03d84dc8b2293884
- Cited by
- 1,270
- References
- 213
- Citations by year
- 2026: 99 · 2025: 120 · 2024: 104 · 2023: 117 · 2022: 148 · 2021: 169 · 2020: 116 · 2019: 112 · 2018: 116 · 2017: 83 · 2016: 75 · 2015: 6
- FWCI
- 80.93
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Keywords
- Cushing's syndrome, hypercortisolism, surgical resection, bilateral adrenalectomy, radiotherapy, corticotropinoma, comorbidity management, treatment selection
- MeSH terms
- Adrenal Gland Neoplasms, Adrenalectomy, Cushing Syndrome, Endocrinology, Humans, Patient Care Planning, Pituitary Neoplasms, Recurrence, Remission Induction, Evidence-Based Medicine, Consensus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.